ECSP972210A - NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE - Google Patents

NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE

Info

Publication number
ECSP972210A
ECSP972210A ECSP972210A ECSP972210A EC SP972210 A ECSP972210 A EC SP972210A EC SP972210 A ECSP972210 A EC SP972210A EC SP972210 A ECSP972210 A EC SP972210A
Authority
EC
Ecuador
Prior art keywords
heteroarylalkyl
group
hydrogen atoms
fluorine
diseases
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Yoshimi Tsuchya
Hirokazu Ohsawa
Kumiko Kawarami
Kenji Ohwaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972210 priority Critical patent/ECSP972210A/en
Publication of ECSP972210A publication Critical patent/ECSP972210A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere a nuevos derivados de piperidina 1.4 disustituída que contienen flúor representada por la fórmula general I: (gráfico) y sus sales farmacéuticamente aceptables donde: Ar representa un grupo de arilo o un grupo de heteroarilo que tiene entre 1 y 2 heteroátomos seleccionados de un grupo formado por nitrógeno, oxígeno y azufre (cualquiera de 1 a 3 átomos de hidrógeno sobre el anillo de dicho grupo de arilo o heteroarilo puede ser sustituído con un alquilo menor, amino o alquilamino menor), R1 representa al cicloalquilo C3-C6 cuyos de 1 a 4 átomos de hidrógeno pueden estar sustituídos con átomo(s) de flúor. R2 representa grupos alifáticos saturados o no saturados de C5-C15 cualquiera de cuyos 1 a 6 átomos de hidrógeno pueden sustituirse con átomo (s) de flúor, grupos de aralquilo, arilalquenilo, heteroarilalquilo o heteroarilalquenilo que tienen entre 1 y 2 heteroátomos seleccionados del grupo formado por nitrógeno en el anillo en dicho aralquilo, arialquenilo, heteroarilalquilo o heteroarilalquenilo puede estar sustituido con un alquilo menor, trifluorometilo, ciano, hidroxilo, nitro alcoxicarbonilo menor, halógeno, alcoxi menor, amino o alquilamino menor), y X es = o NH, si al menos uno de R1 y R2 contiene uno o más átomos de flúor. Los compuestos de la presente invención tienen un solo un antagonismo potente y selectivo para los receptores M3 muscarínicos sino también tienen pocos efectos colaterales. Más aún, exhiben una excelente actividad oral, duración de acción y farmacocinética. Por lo tanto son útiles para el tratamiento y profilaxis de las enfermedades respiratorias, las enfermedades urinarias y enfermedades digestivas.This invention relates to novel fluorine-containing disubstituted piperidine 1.4 derivatives represented by the general formula I: (graph) and its pharmaceutically acceptable salts where: Ar represents an aryl group or a heteroaryl group having between 1 and 2 selected heteroatoms of a group consisting of nitrogen, oxygen and sulfur (any of 1 to 3 hydrogen atoms on the ring of said aryl or heteroaryl group can be substituted with a lower alkyl, amino or lower alkylamino), R1 represents C3-C6 cycloalkyl of which 1 to 4 hydrogen atoms may be replaced with fluorine atom (s). R2 represents saturated or unsaturated aliphatic groups of C5-C15 any of which 1 to 6 hydrogen atoms can be replaced with fluorine atom (s), aralkyl, arylalkenyl, heteroarylalkyl or heteroarylalkyl groups having 1 to 2 heteroatoms selected from the group formed by nitrogen in the ring in said aralkyl, arialkenyl, heteroarylalkyl, or heteroarylalkyl may be substituted with a lower alkyl, trifluoromethyl, cyano, hydroxyl, nitro-lower alkoxycarbonyl, halogen, lower alkoxy, amino or lower alkylamino), and X is = or NH , if at least one of R1 and R2 contains one or more fluorine atoms. The compounds of the present invention have only one potent and selective antagonism to muscarinic M3 receptors but also have few side effects. Furthermore, they exhibit excellent oral activity, duration of action, and pharmacokinetics. Therefore they are useful for the treatment and prophylaxis of respiratory diseases, urinary diseases and digestive diseases.

ECSP972210 1997-07-31 1997-07-31 NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE ECSP972210A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972210 ECSP972210A (en) 1997-07-31 1997-07-31 NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972210 ECSP972210A (en) 1997-07-31 1997-07-31 NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE

Publications (1)

Publication Number Publication Date
ECSP972210A true ECSP972210A (en) 1998-09-22

Family

ID=42043040

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972210 ECSP972210A (en) 1997-07-31 1997-07-31 NEW DERIVATIVES OF PIPERIDINE 1,4- DISSTITUTED THAT CONTAINS FLUORINE

Country Status (1)

Country Link
EC (1) ECSP972210A (en)

Similar Documents

Publication Publication Date Title
CO4960641A1 (en) DERIVATIVES OF PIPERIDINE 1,4-DISSTITUTED CONTAINING FLUORINE
AR033379A1 (en) DIFENILUREA COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR016817A1 (en) DERIVATIVES OF FENILUREA OR FENILTIOUREA, PROCEDURE FOR PREPARATION, COLLECTION OF COMPOUNDS, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
CO5550434A2 (en) SUBSTITUTED OXAZOLIDINONES FOR COMBINATION THERAPY
UY26872A1 (en) DERIVATIVES OF THE 4- PIRIDINE PHENYL
UY27357A1 (en) NEW ANTIDIABETIC AGENTS.
PE20061332A1 (en) PIPERIDINE DERIVATIVES AS RENIN INHIBITING AGENTS
ECSP055987A (en) HETEROARILCARBAMOILBENCENO DERIVATIVES
UY27918A1 (en) BENZODIOXOL DERIVATIVES
ES2081966T3 (en) BENZOCONDENSATED HETERO-CYCLE DERIVATIVES CONTAINING N.
ATE541833T1 (en) NITROGEN-CONTAINING COMPOUNDS WITH KINASE-INHIBITING EFFECTS AND MEDICATIONS CONTAINING SAME
CO5560610A2 (en) DERIVATIVES OF YODOBENZOPIRAN-4-ONA THAT HAVE FUNGICIDE ACTIVITY
MX9300988A (en) ANTINEOPLASTIC AGENTS OF QUINOBENZOXAZINE, QUINOBENZOTIAZINE AND PIRIDO-ACRIDINA AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
RU2005113153A (en) NEW PYRIMIDINAMIDE DERIVATIVES AND THEIR APPLICATION
CO4970744A1 (en) DANDRUFFS AND APOPTOSIS
PA8575001A1 (en) FLUOROBENZAMIDS AS MAOB INHIBITORS
AR016644A1 (en) COMPOUNDS OF 2-AMINOPIRIDINAS WITH ALCOXI RAMIFIED SUBSTITUTES, PHARMACEUTICAL COMPOSITION AND USE FOR THE MANUFACTURE OF MEDICINES
AR036812A1 (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
PE20040750A1 (en) DERIVATIVES OF N- (1-ACETYLPIPERIDIN-4-IL) -4-BENZIDRIL-2-ISOPROPILPIPERAZIN-1-CARBOXAMIDE AS INHIBITORS OF 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3
CO5700773A2 (en) BENCIMIDAZOL DERIVATIVES
ECSP066415A (en) 2-CARBONILAMINO-6-PIPERIDINAMINOPIRIDINAS REPLACED AND 1-CARBONILAMINO-3-PIPERIDINAMINOBENZENOS REPLACED AS 5-HT1F AGONISTS
PE20040765A1 (en) 4-AMINO PIPERIDINES N, N-DISUSTITUTED AS INHIBITORS OF MONOAMINE UPTAKE
AR041898A1 (en) DERIVATIVES OF 4 (FENIL-PIPERAZINIL-METIL) BENZAMIDA AND ITS USES FOR THE TREATMENT OF PAIN AND GASTROINTESTINAL DISORDERS
AR054102A1 (en) DERIVATIVES OF FENIL-PIPERAZINA-METANONA. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS
AR053340A1 (en) DERIVATIVES OF TRIFLUORMETILBENZAMIDA AND ITS THERAPEUTIC USES